News Celgene to file potential MS blockbuster this year Success with ozanimod would justify $7.2 billion outlay for Receptos.
News Teva's CEO Vigodman steps down Firm searches for new leader, chairman takes over on interim basis.
Views & Analysis Digital Health Round-up - Siemens and Biogen take on MS imag... A round-up of this week's digital healthcare news. Marco Ricci reports.
News Biogen protects Tecfidera via $1.25bn deal with Forward Biogen could also pay royalties to Forward.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
